Paolo Tombesi - Feb 9, 2022 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
EVP & Chief Financial Officer
Signature
/s/ Paolo Tombesi
Stock symbol
TPTX
Transactions as of
Feb 9, 2022
Transactions value $
$0
Form type
4
Date filed
2/11/2022, 05:11 PM
Previous filing
Jul 27, 2021
Next filing
Jul 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Award $0 +16.3K +119.73% $0.00 29.9K Feb 9, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Award $0 +58.6K $0.00 58.6K Feb 9, 2022 Common Stock 58.6K $37.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
F2 1/48th of the shares vest monthly following February 9, 2022.